Abbott Laboratories (ABT) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Abbott Laboratories  (NYSE: ABT)
 

Abbott Laboratories Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Abbott Laboratories inventory turnover ratio, the Abbott Laboratories's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 2.95 in the third quarter 2026, yet the ratio remained below the average, as ABT's market remain challenging.Average processing period, for Abbott Laboratories's inventories remained unchanged at 124 days, in the Sep 30 2026 quarter.

Within Healthcare sector 135 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 1273, from total ranking in the second quarter 2026 at 1467.

ABT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Abbott Laboratories Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABT Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 9.38 % 5.19 % 5.27 % 4.75 % -1.54 %
Y / Y Cost of Sales Growth 10.9 % 9.7 % 9.44 % -0.4 % 8.02 %
Inventory Turnover Ratio (TTM) 2.95 2.94 2.91 2.88 2.92
ABT's Total Ranking # 1273 # 1467 # 1290 # 1300 # 1320
Average inventory processing period 124 124 125 127 125
Seq. Inventory Growth 0.3 % 4.66 % 7.72 % -3.28 % -3.54 %
Seq. Cost of Sales Growth 5.69 % 8.9 % -0.65 % -3.01 % 4.55 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 33
Healthcare Sector # 136
Overall Market # 1273

Inventory Turnover Ratio Statistics
High Average Low
4.75 3.52 2.69
(June 30. 2011)   (Dec 31 2023)



ABT Company Profile >> Back to ABT Efficiency Comparisons >> Compare ABT Inventory Turnover Ratio to its Competitors

Financial Statements
Abbott Laboratories's Inventories $ 7,337 Millions Visit ABT's Balance sheet
Abbott Laboratories's Cost of Revenues TTM $ 20,765 Millions Visit ABT's Income Statement
What are ABT's Sales? Visit ABT's Sales by Segment

Other Inventory Turnover Ratios
Abbott Laboratories's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ABT's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ABT's Competitors
Inventory Turnover Ratio for ABT's Suppliers
Inventory Turnover Ratio for ABT's Customers

You may also want to know
ABT's Sales Growth Rates ABT's Pe Price to earnings ratio ABT's Receivables Turnover Ratio ABT's Stock Quote
ABT's Net Income Growth Rates ABT's Ps Price to Sales ratio ABT's Sales per Employee ABT's Asset Turnover Ratio
ABT's Net Margin ABT's Pb Price to Book ratio ABT's Financial Strength Ratios ABT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Phathom Pharmaceuticals Inc   7.76 $ 53.106  Millions$ 7  Millions
Carlisle Companies Incorporated  6.99 $ 3,406.400  Millions$ 488  Millions
Caredx Inc   6.42 $ 111.106  Millions$ 17  Millions
Bristol myers Squibb Company  5.65 $ 15,389.000  Millions$ 2,722  Millions
Avantor Inc   5.48 $ 4,539.200  Millions$ 828  Millions
Tactile Systems Technology Inc   5.25 $ 82.718  Millions$ 16  Millions
Integer Holdings Corporation  4.98 $ 1,376.268  Millions$ 276  Millions
Ge Healthcare Technologies Inc   4.69 $ 11,372.000  Millions$ 2,425  Millions
West Pharmaceutical Services Inc   4.69 $ 2,120.200  Millions$ 452  Millions
Henry Schein Inc   4.63 $ 9,395.000  Millions$ 2,031  Millions
Idexx Laboratories Inc  4.52 $ 1,743.379  Millions$ 386  Millions
Medinotec Inc   4.28 $ 5.143  Millions$ 1  Millions
3m Company  4.02 $ 15,267.000  Millions$ 3,801  Millions
Novocure Limited  3.98 $ 166.721  Millions$ 42  Millions
Incyte Corporation  3.79 $ 439.399  Millions$ 116  Millions
Baxter International Inc   3.57 $ 8,117.000  Millions$ 2,277  Millions
Bausch Health Companies Inc   3.54 $ 4,518.000  Millions$ 1,276  Millions
Exelixis Inc   3.49 $ 93.324  Millions$ 27  Millions
Abbvie Inc   3.40 $ 17,346.000  Millions$ 5,108  Millions
Gilead Sciences Inc   3.30 $ 6,219.000  Millions$ 1,884  Millions
Teva Pharmaceutical Industries Limited  3.16 $ 8,011.000  Millions$ 2,537  Millions
Msa Safety Inc  3.00 $ 1,063.235  Millions$ 354  Millions
Mimedx Group Inc   2.98 $ 70.562  Millions$ 24  Millions
Ligand Pharmaceuticals Incorporated  2.93 $ 34.495  Millions$ 12  Millions
Neogen Corporation  2.89 $ 464.774  Millions$ 161  Millions
Zevra Therapeutics Inc   2.82 $ 6.736  Millions$ 2  Millions
Biomerica Inc   2.65 $ 4.297  Millions$ 2  Millions
Dexcom Inc   2.65 $ 1,867.500  Millions$ 705  Millions
Angiodynamics Inc   2.50 $ 142.709  Millions$ 57  Millions
Pro dex Inc   2.45 $ 53.753  Millions$ 22  Millions

Date modified: 2026-11-05T14:27:26+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.